{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:23:59Z","timestamp":1794338639660,"version":"4.9.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31872825"],"award-info":[{"award-number":["31872825"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32022013"],"award-info":[{"award-number":["32022013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270650"],"award-info":[{"award-number":["32270650"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32000469"],"award-info":[{"award-number":["32000469"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100466"],"award-info":[{"award-number":["32100466"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010229","name":"Natural Science Foundation of Tianjin Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["20JCJQJC00290"],"award-info":[{"award-number":["20JCJQJC00290"]}],"id":[{"id":"10.13039\/501100010229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M692408"],"award-info":[{"award-number":["2021M692408"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","award":["18JCYBJC42400"],"award-info":[{"award-number":["18JCYBJC42400"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Enhancer deregulation is a well-established pro-tumorigenic mechanism but whether it plays a regulatory role in tumor immunity is largely unknown. Here, we demonstrate that tumor cell ablation of mixed-lineage leukemia 3 and 4 (MLL3 and MLL4, also known as KMT2C and KMT2D, respectively), two enhancer-associated histone H3 lysine 4 (H3K4) mono-methyltransferases, increases tumor immunogenicity and promotes anti-tumor T cell response. Mechanistically, MLL4 ablation attenuates the expression of RNA-induced silencing complex (RISC) and DNA methyltransferases through decommissioning enhancers\/super-enhancers, which consequently lead to transcriptional reactivation of the double-stranded RNA (dsRNA)-interferon response and gasdermin D (GSDMD)-mediated pyroptosis, respectively. More importantly, we reveal that both the dsRNA-interferon signaling and GSDMD-mediated pyroptosis are of critical importance to the increased anti-tumor immunity and improved immunotherapeutic efficacy in MLL4-ablated tumors. Thus, our findings establish tumor cell enhancers as an additional layer of immune evasion mechanisms and suggest the potential of targeting enhancers or their upstream and\/or downstream molecular pathways to overcome immunotherapeutic resistance in cancer patients.<\/jats:p>","DOI":"10.1038\/s41467-022-34253-1","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T20:29:15Z","timestamp":1667420955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Enhancer decommissioning by MLL4 ablation elicits dsRNA-interferon signaling and GSDMD-mediated pyroptosis to potentiate anti-tumor immunity"],"prefix":"10.1038","volume":"13","author":[{"given":"Hanhan","family":"Ning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8567-018X","authenticated-orcid":false,"given":"Yang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renyong","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaimin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5301-7610","authenticated-orcid":false,"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2536-4180","authenticated-orcid":false,"given":"Zhe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0255-4376","authenticated-orcid":false,"given":"Yi","family":"Ba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9459-0472","authenticated-orcid":false,"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8929-0651","authenticated-orcid":false,"given":"Deqing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"34253_CR1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. Cell 168, 707\u2013723 (2017).","journal-title":"Cell"},{"key":"34253_CR2","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas, A. & Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. Science 359, 1350\u20131355 (2018).","journal-title":"Science"},{"key":"34253_CR3","doi-asserted-by":"publisher","unstructured":"Lu, C. et al. DNA sensing in mismatch repair-deficient tumor cells is essential for anti-tumor immunity. Cancer Cell, https:\/\/doi.org\/10.1016\/j.ccell.2020.11.006 (2020).","DOI":"10.1016\/j.ccell.2020.11.006"},{"key":"34253_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","volume":"348","author":"NA Rizvi","year":"2015","unstructured":"Rizvi, N. A. et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348, 124\u2013128 (2015).","journal-title":"Science"},{"key":"34253_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.aad0095","volume":"350","author":"EM Van Allen","year":"2015","unstructured":"Van Allen, E. M. et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science 350, 207\u2013211 (2015).","journal-title":"Science"},{"key":"34253_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1126\/science.aau0447","volume":"364","author":"R Mandal","year":"2019","unstructured":"Mandal, R. et al. Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response. Science 364, 485\u2013491 (2019).","journal-title":"Science"},{"key":"34253_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","volume":"167","author":"J Gao","year":"2016","unstructured":"Gao, J. et al. Loss of IFN-gamma pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy. Cell 167, 397\u2013404 e399 (2016).","journal-title":"Cell"},{"key":"34253_CR8","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1604958","volume":"375","author":"JM Zaretsky","year":"2016","unstructured":"Zaretsky, J. M. et al. Mutations associated with acquired resistance to PD-1 blockade in melanoma. N. Engl. J. Med. 375, 819\u2013829 (2016).","journal-title":"N. Engl. J. Med."},{"key":"34253_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","volume":"7","author":"DS Shin","year":"2017","unstructured":"Shin, D. S. et al. Primary resistance to PD-1 blockade mediated by JAK1\/2 mutations. Cancer Discov. 7, 188\u2013201 (2017).","journal-title":"Cancer Discov."},{"key":"34253_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01062-w","volume":"8","author":"M Sade-Feldman","year":"2017","unstructured":"Sade-Feldman, M. et al. Resistance to checkpoint blockade therapy through inactivation of antigen presentation. Nat. Commun. 8, 1136 (2017).","journal-title":"Nat. Commun."},{"key":"34253_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41586-020-2682-1","volume":"585","author":"Y Bian","year":"2020","unstructured":"Bian, Y. et al. Cancer SLC43A2 alters T cell methionine metabolism and histone methylation. Nature 585, 277\u2013282 (2020).","journal-title":"Nature"},{"key":"34253_CR12","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.cmet.2021.04.001","volume":"33","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance. Cell Metab. 33, 1221\u20131233 e1211 (2021).","journal-title":"Cell Metab."},{"key":"34253_CR13","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1126\/science.aav2588","volume":"366","author":"RD Leone","year":"2019","unstructured":"Leone, R. D. et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science 366, 1013\u20131021 (2019).","journal-title":"Science"},{"key":"34253_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrc.2017.117","volume":"18","author":"S Spranger","year":"2018","unstructured":"Spranger, S. & Gajewski, T. F. Impact of oncogenic pathways on evasion of antitumour immune responses. Nat. Rev. Cancer 18, 139\u2013147 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"34253_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature23270","volume":"547","author":"RT Manguso","year":"2017","unstructured":"Manguso, R. T. et al. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. Nature 547, 413\u2013418 (2017).","journal-title":"Nature"},{"key":"34253_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ccell.2019.08.008","volume":"36","author":"ML Burr","year":"2019","unstructured":"Burr, M. L. et al. An evolutionarily conserved function of polycomb silences the MHC Class I antigen presentation pathway and enables immune evasion in cancer. Cancer cell 36, 385\u2013401 e388 (2019).","journal-title":"Cancer cell"},{"key":"34253_CR17","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.celrep.2017.07.007","volume":"20","author":"D Zingg","year":"2017","unstructured":"Zingg, D. et al. The histone methyltransferase Ezh2 controls mechanisms of adaptive resistance to tumor immunotherapy. Cell Rep. 20, 854\u2013867 (2017).","journal-title":"Cell Rep."},{"key":"34253_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature15520","volume":"527","author":"D Peng","year":"2015","unstructured":"Peng, D. et al. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature 527, 249\u2013253 (2015).","journal-title":"Nature"},{"key":"34253_CR19","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","volume":"162","author":"KB Chiappinelli","year":"2015","unstructured":"Chiappinelli, K. B. et al. Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses. Cell 162, 974\u2013986 (2015).","journal-title":"Cell"},{"key":"34253_CR20","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","volume":"162","author":"D Roulois","year":"2015","unstructured":"Roulois, D. et al. DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts. Cell 162, 961\u2013973 (2015).","journal-title":"Cell"},{"key":"34253_CR21","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cell.2018.05.052","volume":"174","author":"W Sheng","year":"2018","unstructured":"Sheng, W. et al. LSD1 ablation stimulates anti-tumor immunity and enables checkpoint blockade. Cell 174, 549\u2013563 e519 (2018).","journal-title":"Cell"},{"key":"34253_CR22","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-021-03994-2","volume":"598","author":"SM Zhang","year":"2021","unstructured":"Zhang, S. M. et al. KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements. Nature 598, 682\u2013687 (2021).","journal-title":"Nature"},{"key":"34253_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03520-4","author":"GK Griffin","year":"2021","unstructured":"Griffin, G. K. et al. Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity. Nature https:\/\/doi.org\/10.1038\/s41586-021-03520-4 (2021).","journal-title":"Nature"},{"key":"34253_CR24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nsmb.2784","volume":"21","author":"E Smith","year":"2014","unstructured":"Smith, E. & Shilatifard, A. Enhancer biology and enhanceropathies. Nat. Struct. Mol. Biol. 21, 210\u2013219 (2014).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"34253_CR25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.tig.2019.04.002","volume":"35","author":"D Dorsett","year":"2019","unstructured":"Dorsett, D. The many roles of cohesin in drosophila gene transcription. Trends Genet.: TIG 35, 542\u2013551 (2019).","journal-title":"Trends Genet.: TIG"},{"key":"34253_CR26","doi-asserted-by":"publisher","first-page":"21931","DOI":"10.1073\/pnas.1016071107","volume":"107","author":"MP Creyghton","year":"2010","unstructured":"Creyghton, M. P. et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl Acad. Sci. U.S.A. 107, 21931\u201321936 (2010).","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"34253_CR27","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1101\/gad.201327.112","volume":"26","author":"HM Herz","year":"2012","unstructured":"Herz, H. M. et al. Enhancer-associated H3K4 monomethylation by Trithorax-related, the Drosophila homolog of mammalian Mll3\/Mll4. Genes Dev. 26, 2604\u20132620 (2012).","journal-title":"Genes Dev."},{"key":"34253_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1126\/science.aba7300","volume":"370","author":"R Li","year":"2020","unstructured":"Li, R. et al. Macroscopic somatic clonal expansion in morphologically normal human urothelium. Science 370, 82\u201389 (2020).","journal-title":"Science"},{"key":"34253_CR29","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1158\/2159-8290.CD-20-1092","volume":"11","author":"JC Fowler","year":"2021","unstructured":"Fowler, J. C. et al. Selection of oncogenic mutant clones in normal human skin varies with body site. Cancer Discov. 11, 340\u2013361 (2021).","journal-title":"Cancer Discov."},{"key":"34253_CR30","doi-asserted-by":"publisher","unstructured":"Sze, C. C. & Shilatifard, A. MLL3\/MLL4\/COMPASS family on epigenetic regulation of enhancer function and cancer. Cold Spring Harb. Perspect. Med. 6, https:\/\/doi.org\/10.1101\/cshperspect.a026427 (2016).","DOI":"10.1101\/cshperspect.a026427"},{"key":"34253_CR31","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1128\/MCB.00203-13","volume":"33","author":"MA Morgan","year":"2013","unstructured":"Morgan, M. A. & Shilatifard, A. Drosophila SETs its sights on cancer: Trr\/MLL3\/4 COMPASS-like complexes in development and disease. Mol. Cell. Biol. 33, 1698\u20131701 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"34253_CR32","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1128\/MCB.01181-13","volume":"33","author":"D Hu","year":"2013","unstructured":"Hu, D. et al. The MLL3\/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers. Mol. Cell. Biol. 33, 4745\u20134754 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"34253_CR33","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.molcel.2014.02.033","volume":"53","author":"HM Herz","year":"2014","unstructured":"Herz, H. M., Hu, D. & Shilatifard, A. Enhancer malfunction in cancer. Mol. cell 53, 859\u2013866 (2014).","journal-title":"Mol. cell"},{"key":"34253_CR34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ccell.2020.03.005","volume":"37","author":"H Alam","year":"2020","unstructured":"Alam, H. et al. KMT2D deficiency impairs super-enhancers to confer a glycolytic vulnerability in lung cancer. Cancer cell 37, 599\u2013617 e597 (2020).","journal-title":"Cancer cell"},{"key":"34253_CR35","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/nm.3943","volume":"21","author":"A Ortega-Molina","year":"2015","unstructured":"Ortega-Molina, A. et al. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development. Nat. Med. 21, 1199\u20131208 (2015).","journal-title":"Nat. Med."},{"key":"34253_CR36","doi-asserted-by":"publisher","first-page":"e01503","DOI":"10.7554\/eLife.01503","volume":"2","author":"JE Lee","year":"2013","unstructured":"Lee, J. E. et al. H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation. eLife 2, e01503 (2013).","journal-title":"eLife"},{"key":"34253_CR37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","volume":"20","author":"P Broz","year":"2020","unstructured":"Broz, P., Pelegrin, P. & Shao, F. The gasdermins, a protein family executing cell death and inflammation. Nat. Rev. Immunol. 20, 143\u2013157 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"34253_CR38","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660\u2013665 (2015).","journal-title":"Nature"},{"key":"34253_CR39","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki, N. et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526, 666\u2013671 (2015).","journal-title":"Nature"},{"key":"34253_CR40","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41573-021-00154-z","volume":"20","author":"X Liu","year":"2021","unstructured":"Liu, X., Xia, S., Zhang, Z., Wu, H. & Lieberman, J. Channelling inflammation: gasdermins in physiology and disease. Nat. Rev. Drug Discov. 20, 384\u2013405 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"34253_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","volume":"579","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature 579, 415\u2013420 (2020).","journal-title":"Nature"},{"key":"34253_CR42","doi-asserted-by":"publisher","unstructured":"Zhou, Z. et al. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Science 368, https:\/\/doi.org\/10.1126\/science.aaz7548 (2020).","DOI":"10.1126\/science.aaz7548"},{"key":"34253_CR43","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.aao1710","volume":"359","author":"D Pan","year":"2018","unstructured":"Pan, D. et al. A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing. Science 359, 770\u2013775 (2018).","journal-title":"Science"},{"key":"34253_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","volume":"165","author":"W Hugo","year":"2016","unstructured":"Hugo, W. et al. Genomic and transcriptomic features of response to Anti-PD-1 therapy in metastatic melanoma. Cell 165, 35\u201344 (2016).","journal-title":"Cell"},{"key":"34253_CR45","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan, S. et al. TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554, 544\u2013548 (2018).","journal-title":"Nature"},{"key":"34253_CR46","doi-asserted-by":"publisher","first-page":"e1002309","DOI":"10.1371\/journal.pmed.1002309","volume":"14","author":"A Snyder","year":"2017","unstructured":"Snyder, A. et al. Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: an exploratory multi-omic analysis. PLoS Med. 14, e1002309 (2017).","journal-title":"PLoS Med."},{"key":"34253_CR47","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nri3339","volume":"12","author":"KS Kobayashi","year":"2012","unstructured":"Kobayashi, K. S. & van den Elsen, P. J. NLRC5: a key regulator of MHC class I-dependent immune responses. Nat. Rev. Immunol. 12, 813\u2013820 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"34253_CR48","doi-asserted-by":"publisher","unstructured":"Kalbasi, A. et al. Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma. Sci. Transl. Med. 12, https:\/\/doi.org\/10.1126\/scitranslmed.abb0152 (2020).","DOI":"10.1126\/scitranslmed.abb0152"},{"key":"34253_CR49","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth, N., Wicha, M. S. & Zou, W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat. Rev. Immunol. 17, 559\u2013572 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"34253_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02357-4","volume":"22","author":"N Jansz","year":"2021","unstructured":"Jansz, N. & Faulkner, G. J. Endogenous retroviruses in the origins and treatment of cancer. Genome Biol. 22, 147 (2021).","journal-title":"Genome Biol."},{"key":"34253_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41586-020-2844-1","volume":"588","author":"P Mehdipour","year":"2020","unstructured":"Mehdipour, P. et al. Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency. Nature 588, 169\u2013173 (2020).","journal-title":"Nature"},{"key":"34253_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-pathmechdis-012419-032633","volume":"15","author":"KH Burns","year":"2020","unstructured":"Burns, K. H. Our conflict with transposable elements and its implications for human disease. Annu. Rev. Pathol. 15, 51\u201370 (2020).","journal-title":"Annu. Rev. Pathol."},{"key":"34253_CR53","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nsmb.2827","volume":"21","author":"E White","year":"2014","unstructured":"White, E., Schlackow, M., Kamieniarz-Gdula, K., Proudfoot, N. J. & Gullerova, M. Human nuclear Dicer restricts the deleterious accumulation of endogenous double-stranded RNA. Nat. Struct. Mol. Biol. 21, 552\u2013559 (2014).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"34253_CR54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi, L., Buque, A., Kepp, O., Zitvogel, L. & Kroemer, G. Immunogenic cell death in cancer and infectious disease. Nat. Rev. Immunol. 17, 97\u2013111 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"34253_CR55","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.molcel.2018.04.028","volume":"70","author":"SS Dhar","year":"2018","unstructured":"Dhar, S. S. et al. MLL4 is required to maintain broad H3K4me3 peaks and super-enhancers at tumor suppressor genes. Mol. cell 70, 825\u2013841 e826 (2018).","journal-title":"Mol. cell"},{"key":"34253_CR56","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.molcel.2017.04.018","volume":"66","author":"KM Dorighi","year":"2017","unstructured":"Dorighi, K. M. et al. Mll3 and Mll4 facilitate enhancer RNA synthesis and transcription from promoters independently of H3K4 monomethylation. Mol. Cell 66, 568\u2013576 e564 (2017).","journal-title":"Mol. Cell"},{"key":"34253_CR57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547, 99\u2013103 (2017).","journal-title":"Nature"},{"key":"34253_CR58","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/gcc.20636","volume":"48","author":"N Saeki","year":"2009","unstructured":"Saeki, N. et al. Distinctive expression and function of four GSDM family genes (GSDMA-D) in normal and malignant upper gastrointestinal epithelium. Genes Chromosomes Cancer 48, 261\u2013271 (2009).","journal-title":"Genes Chromosomes Cancer"},{"key":"34253_CR59","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/1751-2980.12576","volume":"19","author":"WJ Wang","year":"2018","unstructured":"Wang, W. J. et al. Downregulation of gasdermin D promotes gastric cancer proliferation by regulating cell cycle-related proteins. J. Digest. Dis. 19, 74\u201383 (2018).","journal-title":"J. Digest. Dis."},{"key":"34253_CR60","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","volume":"153","author":"WA Whyte","year":"2013","unstructured":"Whyte, W. A. et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307\u2013319 (2013).","journal-title":"Cell"},{"key":"34253_CR61","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Loven","year":"2013","unstructured":"Loven, J. et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153, 320\u2013334 (2013).","journal-title":"Cell"},{"key":"34253_CR62","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","volume":"20","author":"MVC Greenberg","year":"2019","unstructured":"Greenberg, M. V. C. & Bourc\u2019his, D. The diverse roles of DNA methylation in mammalian development and disease. Nat. Rev. Mol. Cell Biol. 20, 590\u2013607 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"34253_CR63","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-018-0751-5","volume":"564","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Stella safeguards the oocyte methylome by preventing de novo methylation mediated by DNMT1. Nature 564, 136\u2013140 (2018).","journal-title":"Nature"},{"key":"34253_CR64","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1158\/2326-6066.CIR-14-0118","volume":"3","author":"S Chen","year":"2015","unstructured":"Chen, S. et al. Combination of 4-1BB agonist and PD-1 antagonist promotes antitumor effector\/memory CD8 T cells in a poorly immunogenic tumor model. Cancer Immunol. Res. 3, 149\u2013160 (2015).","journal-title":"Cancer Immunol. Res."},{"key":"34253_CR65","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1084\/jem.20160801","volume":"214","author":"VR Juneja","year":"2017","unstructured":"Juneja, V. R. et al. PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity. J. Exp. Med. 214, 895\u2013904 (2017).","journal-title":"J. Exp. Med."},{"key":"34253_CR66","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","volume":"371","author":"A Snyder","year":"2014","unstructured":"Snyder, A. et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N. Engl. J. Med. 371, 2189\u20132199 (2014).","journal-title":"N. Engl. J. Med."},{"key":"34253_CR67","first-page":"6","volume":"2","author":"TH Hsiao","year":"2013","unstructured":"Hsiao, T. H. et al. Utilizing signature-score to identify oncogenic pathways of cholangiocarcinoma. Transl. Cancer Res. 2, 6\u201317 (2013).","journal-title":"Transl. Cancer Res."},{"key":"34253_CR68","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1038\/s41591-019-0654-5","volume":"25","author":"D Liu","year":"2019","unstructured":"Liu, D. et al. Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nat. Med. 25, 1916\u20131927 (2019).","journal-title":"Nat. Med."},{"key":"34253_CR69","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","volume":"35","author":"TN Gide","year":"2019","unstructured":"Gide, T. N. et al. Distinct immune cell populations define response to Anti-PD-1 monotherapy and anti-PD-1\/Anti-CTLA-4 combined therapy. Cancer cell 35, 238\u2013255 e236 (2019).","journal-title":"Cancer cell"},{"key":"34253_CR70","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"ST Kim","year":"2018","unstructured":"Kim, S. T. et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat. Med. 24, 1449\u20131458 (2018).","journal-title":"Nat. Med."},{"key":"34253_CR71","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","volume":"171","author":"N Riaz","year":"2017","unstructured":"Riaz, N. et al. Tumor and microenvironment evolution during immunotherapy with nivolumab. Cell 171, 934\u2013949 e916 (2017).","journal-title":"Cell"},{"key":"34253_CR72","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","volume":"21","author":"JJ Hu","year":"2020","unstructured":"Hu, J. J. et al. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat. Immunol. 21, 736\u2013745 (2020).","journal-title":"Nat. Immunol."},{"key":"34253_CR73","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/nm.3940","volume":"21","author":"J Zhang","year":"2015","unstructured":"Zhang, J. et al. Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis. Nat. Med. 21, 1190\u20131198 (2015).","journal-title":"Nat. Med."},{"key":"34253_CR74","doi-asserted-by":"publisher","first-page":"eabj9141","DOI":"10.1126\/sciadv.abj9141","volume":"7","author":"S Egolf","year":"2021","unstructured":"Egolf, S. et al. MLL4 mediates differentiation and tumor suppression through ferroptosis. Sci. Adv. 7, eabj9141 (2021).","journal-title":"Sci. Adv."},{"key":"34253_CR75","doi-asserted-by":"publisher","unstructured":"Wang, G. et al. CRISPR-GEMM pooled mutagenic screening identifies KMT2D as a major modulator of immune checkpoint blockade. Cancer Discov. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-1448 (2020).","DOI":"10.1158\/2159-8290.CD-19-1448"},{"key":"34253_CR76","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1126\/science.aac9935","volume":"352","author":"SC Casey","year":"2016","unstructured":"Casey, S. C. et al. MYC regulates the antitumor immune response through CD47 and PD-L1. Science 352, 227\u2013231 (2016).","journal-title":"Science"},{"key":"34253_CR77","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrg3199","volume":"13","author":"C Feschotte","year":"2012","unstructured":"Feschotte, C. & Gilbert, C. Endogenous viruses: insights into viral evolution and impact on host biology. Nat. Rev. Genet. 13, 283\u2013296 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"34253_CR78","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.cell.2017.12.016","volume":"172","author":"S Ahmad","year":"2018","unstructured":"Ahmad, S. et al. Breaching self-tolerance to Alu duplex RNA underlies MDA5-mediated inflammation. Cell 172, 797\u2013810 e713 (2018).","journal-title":"Cell"},{"key":"34253_CR79","doi-asserted-by":"publisher","first-page":"16250","DOI":"10.1038\/nmicrobiol.2016.250","volume":"2","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. Induction and suppression of antiviral RNA interference by influenza A virus in mammalian cells. Nat. Microbiol. 2, 16250 (2016).","journal-title":"Nat. Microbiol."},{"key":"34253_CR80","doi-asserted-by":"publisher","unstructured":"Laumont, C. M. et al. Noncoding regions are the main source of targetable tumor-specific antigens. Sci. Transl. Med. 10, https:\/\/doi.org\/10.1126\/scitranslmed.aau5516 (2018).","DOI":"10.1126\/scitranslmed.aau5516"},{"key":"34253_CR81","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1172\/JCI34409C1","volume":"118","author":"Y Takahashi","year":"2008","unstructured":"Takahashi, Y. et al. Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells. J. Clin. Investig. 118, 1099\u20131109 (2008).","journal-title":"J. Clin. Investig."},{"key":"34253_CR82","doi-asserted-by":"publisher","unstructured":"Kayagaki, N. et al. IRF2 transcriptionally induces GSDMD expression for pyroptosis. Sci. Signal. 12, https:\/\/doi.org\/10.1126\/scisignal.aax4917 (2019).","DOI":"10.1126\/scisignal.aax4917"},{"key":"34253_CR83","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nri819","volume":"2","author":"M Barry","year":"2002","unstructured":"Barry, M. & Bleackley, R. C. Cytotoxic T lymphocytes: all roads lead to death. Nat. Rev. Immunol. 2, 401\u2013409 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"34253_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14128","volume":"8","author":"C Rogers","year":"2017","unstructured":"Rogers, C. et al. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic\/pyroptotic cell death. Nat. Commun. 8, 14128 (2017).","journal-title":"Nat. Commun."},{"key":"34253_CR85","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.molcel.2013.07.003","volume":"51","author":"D Hu","year":"2013","unstructured":"Hu, D. et al. The little elongation complex functions at initiation and elongation phases of snRNA gene transcription. Mol. cell 51, 493\u2013505 (2013).","journal-title":"Mol. cell"},{"key":"34253_CR86","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson, V. et al. The immune landscape of cancer. Immunity 48, 812\u2013830 e814 (2018).","journal-title":"Immunity"},{"key":"34253_CR87","doi-asserted-by":"publisher","unstructured":"Wang, L. et al. Enhancing KDM5A and TLR activity improves the response to immune checkpoint blockade. Sci. Translat. Med. 12, https:\/\/doi.org\/10.1126\/scitranslmed.aax2282 (2020).","DOI":"10.1126\/scitranslmed.aax2282"},{"key":"34253_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1028-7","volume":"17","author":"B Li","year":"2016","unstructured":"Li, B. et al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 17, 174 (2016).","journal-title":"Genome Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34253-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34253-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34253-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T08:09:45Z","timestamp":1667549385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34253-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["34253"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-34253-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]},"assertion":[{"value":"8 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6578"}}